(Q53206465)

12 May 2018

title

Autoantibodies to chromogranin A are potential diagnostic biomarkers for non-small cell lung cancer. (English)

1 reference

12 May 2018

1 reference

1 reference

Songnan Qi

1

1 reference

12 May 2018

Mo Huang

2

1 reference

12 May 2018

Huan Teng

3

1 reference

12 May 2018

Yudong Lu

4

1 reference

12 May 2018

Min Jiang

5

1 reference

12 May 2018

Lin Wang

6

1 reference

12 May 2018

Jinfang Shi

7

1 reference

12 May 2018

Qing Ma

8

1 reference

12 May 2018

Guohao Gu

9

1 reference

12 May 2018

Yinqiang Xin

10

1 reference

12 May 2018

Hongwei Ma

11

1 reference

12 May 2018

publication date

18 July 2015

1 reference

12 May 2018

published in

Tumor Biology

1 reference

12 May 2018

volume

36

1 reference

12 May 2018

issue

12

1 reference

12 May 2018

page(s)

9979-9985

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-3794-3

exact match

0 references

cites work

Peptide microarrays for the characterization of antigenic regions of human chromogranin A.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Hormone-negative, chromogranin A-positive endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Chromogranin A is an autoantigen in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Chromogranin A is a T cell antigen in human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Serum autoantibodies as biomarkers for early cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Toward an early diagnosis of lung cancer: an autoantibody signature for squamous cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Chromogranin A and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3794-3

Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer

1 reference

12 December 2020

Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features

1 reference

12 December 2020

Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy

1 reference

12 December 2020

Integrated poly(dimethysiloxane) with an intrinsic nonfouling property approaching "absolute" zero background in immunoassays

1 reference

12 December 2020

Chromogranin A, the major catecholamine storage vesicle soluble protein. Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay.

1 reference

12 December 2020

Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease

1 reference

12 December 2020

The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Improved method for predicting linear B-cell epitopes

1 reference

12 December 2020

10.1007/S13277-015-3794-3

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018